Abstract

Colorectal cancer (CRC) is one of the most prevalent cancers in the world, especially in developed countries. In different studies, the association between CRC and dysbiosis of gut microbiome has been reported. However, most of these works focus on the taxonomic variation of the microbiome, which presents little, if any, functional insight about the reason behind and/or consequences of microbiome dysbiosis. In this study, we used a previously reported metagenome dataset which is obtained by sequencing 156 microbiome samples of healthy individuals as the control group (Co), as well as microbiome samples of patients with advanced colorectal adenoma (Ad) and colorectal carcinoma (Ca). Features of the microbiome samples have been analyzed at the level of species, as well as four functional levels, i.e., gene, KEGG orthology (KO) group, Enzyme Commission (EC) number, and reaction. It was shown that, at each of these levels, certain features exist which show significant changing trends during cancer progression. In the next step, a list of these features were extracted, which were shown to be able to predict the category of Co, Ad, and Ca samples with an accuracy of >85%. When only one group of features (species, gene, KO group, EC number, reaction) was used, KO-related features were found to be the most successful features for classifying the three categories of samples. Notably, species-related features showed the least success in sample classification. Furthermore, by applying an independent test set, we showed that these performance trends are not limited to our original dataset. We determined the most important classification features at each of the four functional levels. We propose that these features can be considered as biomarkers of CRC progression. Finally, we show that the intra-diversity of each sample at the levels of bacterial species and genes is much more than those of the KO groups, EC numbers, and reactions of that sample. Therefore, we conclude that the microbiome diversity at the species level, or gene level, is not necessarily associated with the diversity at the functional level, which again indicates the importance of KO-, EC-, and reaction-based features in metagenome analysis. The source code of proposed method is freely available from https://www.bioinformatics.org/mamed.

Highlights

  • Human microbiome consists of 10–100 trillion symbiotic microbial cells which are harbored by each person (Turnbaugh et al, 2007; Ursell et al, 2013; Magnúsdóttir et al, 2017), which in turn affects the human physiologic aspects such as metabolism, drug interactions, and a variety of diseases

  • We investigated how the functions encoded by gut microbiome may change during Colorectal cancer (CRC) progression

  • “Dataset1” consists of 156 samples extracted from feces of 63 healthy (Co), 47 advanced colorectal adenomas (Ad), and 46 colorectal carcinomas (Ca) individuals (Feng et al, 2015)

Read more

Summary

Introduction

Human microbiome consists of 10–100 trillion symbiotic microbial cells which are harbored by each person (Turnbaugh et al, 2007; Ursell et al, 2013; Magnúsdóttir et al, 2017), which in turn affects the human physiologic aspects such as metabolism, drug interactions, and a variety of diseases. It is estimated that about 500−1000 different bacterial species live in the human gut (Sommer and Bäckhed, 2013), which include approximately 3.3 million different bacterial genes. Some international consortia such as MetaHIT (Qin et al, 2010) and the Human Microbiome Project (HMP) (Huttenhower et al, 2012) have put intensive investments on microbiome research, which highlights the importance of the topic. For treating microbiome-related diseases, different methods have been proposed, including fecal microbiome transplantation (Bakken et al, 2011), prescribing probiotics (Gareau et al, 2010), and changing the diet in the form of probiotics to manipulate the microbiome (Cani et al, 2009)

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.